Placenta previa and placental abruption: nursing reference guide

Antepartum hemorrhage — bleeding during the second or third trimester before delivery — is one of the most dangerous and high-stakes clinical scenarios in obstetric nursing. The two leading causes are placenta previa and placental abruption. Together they account for the vast majority of serious antepartum hemorrhage cases, and both carry significant risk of maternal and fetal mortality if not managed correctly.

These two conditions appear together on virtually every NCLEX pharmacology and OB content exam, and for good reason: they share the same presenting complaint (vaginal bleeding in the third trimester) yet have opposite pathophysiology, opposite physical exam findings, and substantially different management priorities. Understanding how to tell them apart — and what to do for each — is a non-negotiable clinical competency.

Quick comparison: placenta previa vs placental abruption

This table is the core of the article. Use it as your primary study reference when differentiating these two conditions.

Placenta previa

Definition and types

Placenta previa occurs when the placenta implants in the lower uterine segment, covering part or all of the internal cervical os. As the lower uterine segment grows and the cervix begins to efface in late pregnancy, the implanted placenta cannot stretch to accommodate — the vessels tear, and bleeding results.

Current classification (per ACOG) uses two categories:

• Complete (total) previa: the placenta completely covers the internal os. Vaginal delivery is impossible. Cesarean section is mandatory.
• Partial previa: the placenta partially covers the internal os.
• Marginal previa: the placental edge reaches but does not cover the internal os. A trial of vaginal delivery may be considered.
• Low-lying placenta: the placental edge is within 2 cm of the internal os but does not reach it. May resolve as the uterus grows; requires follow-up ultrasound.

Note: older terminology (“low-lying,” “partial,” “complete”) is still used clinically and appears on NCLEX. Know all terms.

Risk factors

• Prior cesarean delivery or uterine surgery (most significant risk factor — scarring disrupts normal implantation)
• Advanced maternal age
• Multiparity
• Prior placenta previa
• Multiple gestation (twins, triplets)
• Smoking
• Cocaine use
• Uterine anomalies (fibroids, septum)
• Assisted reproductive technology (IVF)

Classic presentation

The classic presentation is painless bright red vaginal bleeding in the second or third trimester, often sudden and without warning. There is no associated abdominal pain, no uterine contractions (unless labor has begun), and the uterus is soft on palpation. The bleed may stop spontaneously, recur, and worsen as pregnancy advances.

The first episode of bleeding may be relatively small — a “sentinel bleed.” Subsequent bleeds are often more severe.

Diagnosis

• Transabdominal ultrasound: first-line, identifies placental location in most cases
• Transvaginal ultrasound (TVUS): safe, well-tolerated, and more accurate than transabdominal for posterior placenta and for measuring the exact distance from the placental edge to the internal os — preferred for definitive diagnosis
• Digital vaginal exam: absolutely contraindicated until placenta previa has been excluded by ultrasound. A digital exam in a woman with undiagnosed complete previa can precipitate catastrophic hemorrhage. This is a high-yield NCLEX red flag item.
• Bimanual exam: absolutely contraindicated for the same reason.

Management

Expectant management (for preterm, hemodynamically stable patients):

• Hospitalization for the first episode of bleeding; outpatient management may be considered in stable patients without active bleeding
• Pelvic rest — no intercourse, no vaginal exams, no douching
• Continuous electronic fetal monitoring during active bleeding
• IV access (two large-bore IVs)
• Type and screen (or crossmatch if bleeding is significant)
• Betamethasone 12 mg IM ×2 doses, 24 hours apart, for pregnancies between 24 and 34 weeks to accelerate fetal lung maturity
• Tocolysis (terbutaline) may be used cautiously to suppress contractions and allow betamethasone to work — NOT for ongoing hemorrhage
• Magnesium sulfate for fetal neuroprotection if delivery is expected before 32 weeks

Delivery:

• Complete previa: planned cesarean, typically at 36–37 weeks gestation if stable, or emergent if hemorrhage
• Marginal previa with edge ≥2 cm from os: trial of vaginal labor may be considered
• Placenta accreta spectrum (when placenta invades myometrium) should be suspected in any patient with prior cesarean and anterior previa — requires multidisciplinary planning and potential hysterectomy

Nursing interventions

1. No vaginal examinations — post a clear sign at the bedside. This includes speculum exams unless ordered and previa has been ruled out.
2. Establish two large-bore IV lines (18 gauge or larger)
3. Continuous electronic fetal monitoring
4. Administer supplemental oxygen for fetal compromise
5. Obtain CBC, type and crossmatch, coagulation studies, BMP
6. Monitor pad count and weigh pads to quantify blood loss
7. Bed rest — ambulation restrictions based on severity and gestational age
8. Administer betamethasone as ordered
9. Prepare for emergency cesarean if hemorrhage escalates
10. Emotional support — patients are often terrified and facing prolonged hospitalization

Placental abruption

Definition and grades

Placental abruption (also called abruptio placentae) is the premature separation of a normally implanted placenta from the uterine wall before delivery of the fetus. Blood accumulates between the placenta and the uterine wall — a retroplacental hematoma — disrupting uteroplacental blood flow and threatening fetal oxygen delivery.

The Sher classification grades severity:

• Grade 0: No symptoms; diagnosed retrospectively after delivery by finding a retroplacental clot
• Grade 1 (mild): Mild vaginal bleeding; no fetal distress; no maternal hemodynamic compromise; uterine irritability
• Grade 2 (moderate): Moderate to heavy bleeding; uterine hypertonicity; fetal distress present; maternal tachycardia; no maternal shock
• Grade 3 (severe): Heavy bleeding (may be concealed); fetal death; maternal shock; coagulopathy (DIC) common
  • Grade 3a: without coagulopathy
  • Grade 3b: with coagulopathy (DIC)

Risk factors

• Hypertensive disorders of pregnancy (preeclampsia, chronic hypertension) — most common risk factor
• Abdominal trauma (motor vehicle accident, assault, falls) — even minor trauma can trigger abruption
• Cocaine use — causes intense vasoconstriction, precipitating vessel rupture
• Cigarette smoking
• Prior abruption (recurrence risk 10–15% after one episode, up to 25% after two)
• Premature rupture of membranes (PROM) — sudden uterine decompression
• Multiple gestation
• Polyhydramnios — rapid loss of amniotic fluid
• Advanced maternal age
• Thrombophilias (antiphospholipid syndrome)
• Short umbilical cord

Classic presentation

The classic presentation is sudden, severe abdominal pain with dark red vaginal bleeding and a rigid, board-like abdomen. Uterine hypertonicity — the uterus does not relax between contractions, or there are no discrete contractions at all — is the hallmark physical finding.

Fetal heart rate patterns deteriorate as placental separation reduces oxygen delivery: late decelerations, prolonged decelerations, severe variable decelerations, or a sinusoidal pattern indicating severe fetal anemia.

Concealed vs revealed hemorrhage: In approximately 20–25% of abruptions, the blood does not escape vaginally — it remains trapped behind the placenta. This is concealed hemorrhage. The absence of visible bleeding does not mean the patient is not bleeding significantly. Uterine hypertonicity, pain, and fetal distress without obvious external blood loss should raise immediate suspicion for concealed abruption. The degree of clinical deterioration (maternal shock, fetal compromise) may far exceed what the visible blood loss would predict.

DIC risk

Abruption is one of the leading obstetric triggers of disseminated intravascular coagulation (DIC). The mechanism: placental separation releases tissue thromboplastin (factor III) into the maternal circulation in large quantities, activating the coagulation cascade diffusely. Clotting factors and platelets are consumed faster than they can be replaced — consumptive coagulopathy.

Critical monitoring parameters:

• Fibrinogen: a level below 200 mg/dL is the critical threshold — it predicts progression to severe coagulopathy and is an early, sensitive marker of DIC in this setting (normal pregnancy fibrinogen is 400–600 mg/dL, so even “normal” values for non-pregnant adults may represent significant depletion)
• Platelet count, PT, aPTT, D-dimer
• Signs of DIC: oozing from IV sites, petechiae, inability to form clots

For a detailed DIC nursing reference, see the DIC nursing reference.

Management

Management depends on gestational age, fetal status, and severity of hemorrhage.

Grade 1 (mild, stable, remote from term):

• Hospitalization, continuous monitoring
• May attempt to prolong pregnancy with fetal lung maturity treatment (betamethasone)
• Close surveillance with repeat ultrasound

Grade 2–3 (moderate–severe) or fetal compromise:

• Emergency delivery — cesarean section is the most common route, but rapid vaginal delivery may be attempted if the patient is fully dilated and delivery is imminent
• Aggressive IV fluid resuscitation with two large-bore IVs
• Blood product transfusion (see medications table below)
• Continuous fetal monitoring until delivery
• DIC surveillance and treatment

Fetal death (Grade 3):

• Vaginal delivery may be preferred over cesarean when the fetus has died, to minimize maternal surgical risk
• DIC management is the primary concern

Nursing interventions

1. Establish two large-bore IV lines (16 or 18 gauge) immediately
2. Initiate continuous electronic fetal monitoring
3. Administer oxygen by face mask (8–10 L/min) to optimize fetal oxygenation
4. Draw stat CBC, fibrinogen, PT/aPTT, type and crossmatch, BMP, DIC panel
5. Monitor fibrinogen level serially — this is the most sensitive early indicator of coagulopathy
6. Quantify blood loss; weigh pads; monitor for signs of concealed hemorrhage (pain and fetal distress disproportionate to visible bleeding)
7. Position in left lateral tilt to relieve aortocaval compression
8. Prepare blood products per orders: packed red blood cells (PRBCs), fresh frozen plasma (FFP), cryoprecipitate, platelets
9. Insert urinary catheter; monitor urine output (target ≥30 mL/hr — oliguria signals hemorrhagic shock)
10. Prepare for emergency cesarean: notify OR, anesthesia, neonatology
11. Monitor for signs of DIC: petechiae, oozing from IV sites, hematuria, prolonged clotting

Nursing priority comparison

Medications

NCLEX tips

Tip 1: Painless vs painful bleeding — the single most tested discriminator The hallmark difference between previa and abruption is pain. Placenta previa: painless, bright red bleeding. Placental abruption: painful, dark red bleeding with a rigid uterus. If the question says “painless,” think previa. If it says “sudden severe abdominal pain,” think abruption. This one distinction appears on nearly every OB NCLEX question involving antepartum hemorrhage.

Tip 2: Never perform a digital vaginal exam in suspected placenta previa This is the most commonly tested “what NOT to do” item in OB nursing. If a patient presents with painless third-trimester bleeding and placenta previa has not been excluded, no vaginal exam of any kind may be performed — not a speculum exam, not a digital exam, not a bimanual exam. The correct action is immediate ultrasound. Any NCLEX option that includes “perform a pelvic exam” in this clinical scenario is wrong.

Tip 3: Transvaginal ultrasound is safe in placenta previa — and preferred Students often assume that transvaginal ultrasound is contraindicated in placenta previa because “something is going in the vagina.” This is incorrect. The transvaginal probe does not reach the internal os and does not trigger hemorrhage. It is the standard diagnostic tool for confirming previa and measuring the distance from the placental edge to the os. Digital probing of the os is what is dangerous — not the ultrasound probe.

Tip 4: Fibrinogen is the critical DIC marker in abruption When an NCLEX question describes placental abruption and asks what lab value to monitor most closely, the answer is fibrinogen. A fibrinogen level below 200 mg/dL (in a pregnant patient who should have fibrinogen of 400–600 mg/dL) is the earliest and most sensitive indicator of consumptive coagulopathy. Watch for “normal” fibrinogen levels that are actually low for pregnancy — 250 mg/dL is concerning in an obstetric patient even though it’s within the standard non-pregnant reference range.

Tip 5: Concealed abruption — blood loss exceeds visible bleeding In roughly 20–25% of abruptions, there is no external bleeding — the hematoma is trapped behind the placenta. NCLEX questions may describe severe abdominal pain, a rigid uterus, fetal distress, and maternal hypotension with minimal or no vaginal bleeding. Do not be reassured by the absence of visible blood. The clinical picture (pain, rigidity, fetal compromise) takes precedence. This is also why you must monitor urine output and hemodynamic trends — not just pad counts.

Tip 6: Bimanual exam is contraindicated in both conditions NCLEX will test whether students know that bimanual examination — not just digital vaginal exam — is contraindicated until previa is excluded. This applies to both conditions. In abruption, bimanual exam will not help the diagnosis and risks worsening hemorrhage.

Tip 7: Complete previa always requires cesarean delivery When a question describes complete placenta previa and asks about delivery planning, the answer is cesarean section — there is no clinical scenario in which vaginal delivery is safe with complete previa. The placenta physically obstructs the birth canal, and any attempt at vaginal delivery or labor augmentation risks catastrophic hemorrhage. This is tested in both direct knowledge questions and priority-setting scenarios.

Tip 8: Prioritize in the right order When presented with an NCLEX scenario involving antepartum hemorrhage, the priority sequence is: (1) assess airway/breathing/circulation, (2) establish IV access and begin fluid resuscitation, (3) apply continuous fetal monitoring, (4) draw coagulation labs, (5) prepare for delivery. Performing a vaginal exam is never the first action.

Related topics

The two conditions in this article belong to a broader cluster of high-acuity OB content. For a complete obstetric nursing framework — including labor stages, fetal heart rate interpretation, hypertensive disorders of pregnancy, and full OB medication review — see the obstetric nursing reference.

Antepartum hemorrhage from placental abruption can transition to postpartum hemorrhage after delivery, particularly when DIC has depleted clotting factors. The postpartum hemorrhage nursing reference covers the 4 T’s framework, uterotonic medications, and quantitative blood loss management in detail.

DIC triggered by abruption is managed with blood product replacement — the principles are covered fully in the DIC nursing reference.

Hypertensive disorders of pregnancy (preeclampsia, HELLP syndrome) are the most common underlying risk factor for abruption. See the HELLP syndrome nursing reference for a focused review of that spectrum.

When fetal compromise is identified on electronic fetal monitoring — late decelerations, sinusoidal patterns, or prolonged decelerations — the neonatal nursing reference provides the immediate newborn assessment framework used after emergent delivery, including the Apgar scoring system.

Hemorrhagic shock from either condition follows the same physiologic trajectory covered in the shock nursing reference.